Cancer Systems Imaging
Advances and improvements in diagnostic imaging that are rapidly being translated into the clinic have helped establish a higher quality of patient care. One of the technologies that holds the greatest promise is molecular-genetic imaging. Molecular-genetic imaging provides visualization of normal as well as abnormal cellular processes at the molecular or genetic level.
Faculty in the Department of Cancer Systems Imaging are interested in the development of innovative diagnostics, especially imaging technologies, that allow for early detection of cancer. The faculty is working to develop new diagnostic methods that will be more sensitive and accurate in assessing the extent of disease, determining maintenance pathways of cancer, identifying targets for anti-cancer therapy, and monitoring anticancer genetic and cellular therapies. These novel-imaging approaches would allow physicians to select individualized therapeutic regimens and help predict the efficacy of the therapy early in the treatment.